GENOMICS OPEN ACCESS
GENOMICS can be defined as the branch of
molecular biology which is concerned with structure, function ,
evolution & mapping of the genomes. Each
genome carries the
information to build the organism & allow it grow & develop .
Genomics is an interdisciplinary field of biology focusing on the structure, function, evolution, mapping, and editing of genomes. A
genome is an organism's complete set of DNA, including all of its genes. In contrast to genetics, which refers to the study of individual genes and their roles in inheritance,
genomics aims at the collective characterization and quantification of all of an organism’s genes, their interrelations and influence on the organism Genes may direct the production of proteins with the assistance of enzymes and messenger molecules. In turn, proteins make up body structures such as organs and
tissues as well as control chemical reactions and carry signals between cells.
Eg : skin cell , liver cell
It can also be described as area within
genetics that concerns the
sequencing & analysis of an organism genome.
GENOMICS concept was first developed by Fred sager who first sequenced the complete
genome of a virus & mitochondria.
High Impact List of Articles
-
Vosaroxin for acute myeloid leukemia
Joelle El-Amm & Imad A Tabbara
Review: Clinical Trail Outcomes: Clinical Investigation
-
Vosaroxin for acute myeloid leukemia
Joelle El-Amm & Imad A Tabbara
Review: Clinical Trail Outcomes: Clinical Investigation
-
Vosaroxin for acute myeloid leukemia
Joelle El-Amm & Imad A Tabbara
Review: Clinical Trail Outcomes: Clinical Investigation
-
Vosaroxin for acute myeloid leukemia
Joelle El-Amm & Imad A Tabbara
Review: Clinical Trail Outcomes: Clinical Investigation
-
Vosaroxin for acute myeloid leukemia
Joelle El-Amm & Imad A Tabbara
Review: Clinical Trail Outcomes: Clinical Investigation
-
Vosaroxin for acute myeloid leukemia
Joelle El-Amm & Imad A Tabbara
Review: Clinical Trail Outcomes: Clinical Investigation
-
Vosaroxin for acute myeloid leukemia
Joelle El-Amm & Imad A Tabbara
Review: Clinical Trail Outcomes: Clinical Investigation
-
Vosaroxin for acute myeloid leukemia
Joelle El-Amm & Imad A Tabbara
Review: Clinical Trail Outcomes: Clinical Investigation
-
Quality-adjusted survival as an end point in breast cancer trials
AJ Martin, RJ Simes
Special Issue Article: Clinical Investigation
-
Quality-adjusted survival as an end point in breast cancer trials
AJ Martin, RJ Simes
Special Issue Article: Clinical Investigation
-
Quality-adjusted survival as an end point in breast cancer trials
AJ Martin, RJ Simes
Special Issue Article: Clinical Investigation
-
Quality-adjusted survival as an end point in breast cancer trials
AJ Martin, RJ Simes
Special Issue Article: Clinical Investigation
-
Quality-adjusted survival as an end point in breast cancer trials
AJ Martin, RJ Simes
Special Issue Article: Clinical Investigation
-
Quality-adjusted survival as an end point in breast cancer trials
AJ Martin, RJ Simes
Special Issue Article: Clinical Investigation
-
Quality-adjusted survival as an end point in breast cancer trials
AJ Martin, RJ Simes
Special Issue Article: Clinical Investigation
-
Quality-adjusted survival as an end point in breast cancer trials
AJ Martin, RJ Simes
Special Issue Article: Clinical Investigation
-
Rilpivirine in the treatment of HIV infection: evidence from the ECHO and THRIVE studies
Pedro Cahn
Review: Clinical Trail Outcomes: Clinical Investigation
-
Rilpivirine in the treatment of HIV infection: evidence from the ECHO and THRIVE studies
Pedro Cahn
Review: Clinical Trail Outcomes: Clinical Investigation
-
Rilpivirine in the treatment of HIV infection: evidence from the ECHO and THRIVE studies
Pedro Cahn
Review: Clinical Trail Outcomes: Clinical Investigation
-
Rilpivirine in the treatment of HIV infection: evidence from the ECHO and THRIVE studies
Pedro Cahn
Review: Clinical Trail Outcomes: Clinical Investigation
-
Rilpivirine in the treatment of HIV infection: evidence from the ECHO and THRIVE studies
Pedro Cahn
Review: Clinical Trail Outcomes: Clinical Investigation
-
Rilpivirine in the treatment of HIV infection: evidence from the ECHO and THRIVE studies
Pedro Cahn
Review: Clinical Trail Outcomes: Clinical Investigation
-
Rilpivirine in the treatment of HIV infection: evidence from the ECHO and THRIVE studies
Pedro Cahn
Review: Clinical Trail Outcomes: Clinical Investigation
-
Rilpivirine in the treatment of HIV infection: evidence from the ECHO and THRIVE studies
Pedro Cahn
Review: Clinical Trail Outcomes: Clinical Investigation
-
New developments in the diagnosis and treatment of von Willebrand disease
Emmanuel J Favaloro
Review: Clinical Trail Outcomes: Clinical Investigation
-
New developments in the diagnosis and treatment of von Willebrand disease
Emmanuel J Favaloro
Review: Clinical Trail Outcomes: Clinical Investigation
-
New developments in the diagnosis and treatment of von Willebrand disease
Emmanuel J Favaloro
Review: Clinical Trail Outcomes: Clinical Investigation
-
New developments in the diagnosis and treatment of von Willebrand disease
Emmanuel J Favaloro
Review: Clinical Trail Outcomes: Clinical Investigation
-
New developments in the diagnosis and treatment of von Willebrand disease
Emmanuel J Favaloro
Review: Clinical Trail Outcomes: Clinical Investigation
-
New developments in the diagnosis and treatment of von Willebrand disease
Emmanuel J Favaloro
Review: Clinical Trail Outcomes: Clinical Investigation
-
New developments in the diagnosis and treatment of von Willebrand disease
Emmanuel J Favaloro
Review: Clinical Trail Outcomes: Clinical Investigation
-
New developments in the diagnosis and treatment of von Willebrand disease
Emmanuel J Favaloro
Review: Clinical Trail Outcomes: Clinical Investigation
-
Targeting the BLyS family in autoimmunity: a tale of mouse and man
Jean L Scholz, Eline T Luning Prak, Michael P Cancro
Therapeutic Prospective: Clinical Investigation
-
Targeting the BLyS family in autoimmunity: a tale of mouse and man
Jean L Scholz, Eline T Luning Prak, Michael P Cancro
Therapeutic Prospective: Clinical Investigation
-
Targeting the BLyS family in autoimmunity: a tale of mouse and man
Jean L Scholz, Eline T Luning Prak, Michael P Cancro
Therapeutic Prospective: Clinical Investigation
-
Targeting the BLyS family in autoimmunity: a tale of mouse and man
Jean L Scholz, Eline T Luning Prak, Michael P Cancro
Therapeutic Prospective: Clinical Investigation
-
Targeting the BLyS family in autoimmunity: a tale of mouse and man
Jean L Scholz, Eline T Luning Prak, Michael P Cancro
Therapeutic Prospective: Clinical Investigation
-
Targeting the BLyS family in autoimmunity: a tale of mouse and man
Jean L Scholz, Eline T Luning Prak, Michael P Cancro
Therapeutic Prospective: Clinical Investigation
-
Targeting the BLyS family in autoimmunity: a tale of mouse and man
Jean L Scholz, Eline T Luning Prak, Michael P Cancro
Therapeutic Prospective: Clinical Investigation
-
Targeting the BLyS family in autoimmunity: a tale of mouse and man
Jean L Scholz, Eline T Luning Prak, Michael P Cancro
Therapeutic Prospective: Clinical Investigation
Relevant Topics in Clinical